Skip to main content

Table 2 General nutritional and biochemical indicator measurements of the two groups of ALL patients at the end of the 1st、2nd、3rd and the 4th week (x ± s)

From: Application of Glutamine-enriched nutrition therapy in childhood acute lymphoblastic leukemia

Parameters n ALB (g/L) PA (mg/L) RBP (mg/L) UHI CHI
Treatment group 24      
 Before treatment   29.45 ± 2.87 106.6 ± 21.58 19.56 ± 1.78 1.38 ± 0.48 75.96 ± 11.69
  At the end of 1st week   29.34 ± 3.53 107.5 ± 22.47 19.42 ± 1.94 1.39 ± 0.55 76.21 ± 12.15
  At the end of 2nd week   28.69 ± 2.72 113.47 ± 20.56a 21.76 ± 1.89a 1.35 ± 0.51 72.54 ± 13.21
  At the end of 3rd week   30.78 ± 2.75a 130.52 ± 22.31a 22.34 ± 2.15a 1.42 ± 0.55a 75.88 ± 14.16
  At the end of 4th week   32.57 ± 3.05a 145.71 ± 23.25a 24.59 ± 5.30a 1.49 ± 0.57a 78.22 ± 14.57
Control group 24      
 Before treatment   29.34 ± 3.67 111.78 ± 21.23 20.57 ± 2.32 1.29 ± 0.51 75.79 ± 12.33
  At the end of 1st week   29.11 ± 3.42 110.44 ± 20.54 20.13 ± 2.02 1.28 ± 0.46 75.59 ± 12.08
  At the end of 2nd week   28.77 ± 3.09 100.85 ± 19.78 19.78 ± 2.11 1.26 ± 0.41 73.14 ± 12.79
  At the end of 3rd week   26.90 ± 3.54 112.62 ± 20.01 20.05 ± 2.52 1.15 ± 0.38 72.21 ± 12.58
  At the end of 4th week   27.15 ± 3.29 110.57 ± 21.22 19.52 ± 2.49 1.18 ± 0.36 72.75 ± 12.93
  1. acompared with control group, P < 0.05